In addition, further studies should address specific populations, such as elderly patients or patients with comorbidities (cardiovascular or chronic kidney disease), in order to explore whether copeptin could resolve diagnostic ambiguities arising from false-positive troponin values. Here, AVP is linked to chronic kidney disease.